Helpline: 98400 69000, 04433125000
Make an Enquiry
Helpline: 98400 69000, 04433125000
    Downloads

Donate
  • About Us
    • The History
    • Our Founder
    • Our Logo
    • Governance
    • Legal Details
    • Partners
  • Services
    • Clinical Care
    • Infectious Diseases Laboratory
    • Community Outreach
  • Projects
    • YRG121
    • Camp Rainbow
    • Hepatitis C Free Chennai 2022
    • S. S. Educational Fund
    • Min Siragugal
  • Research
    • Clinical
      • Ongoing
      • Completed
  • News & Events
  • Suniti Symposium
    • 2021
  • COVID-19 Response
  • Donate
  • Contact Us
    • Contact Us
    • Join Us

Archives: Clinicals

A5274/REMEMBER- Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens A Site-Limited Trial of the AIDS Clinical Trials Group (ACTG)

HPTN 052-A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 In Serodiscordant Couples

Randomized Control Trial of Structured Interrupted Generic Antiretroviral Therapy (SIT) versus Continuous Therapy (CT) in HIV-infected Individuals

Prevalence and Incidence of Sexually Transmitted Infections among South Indians at Increased Risk of HIV Infection

Correlates of ART Adherence in Chennai

GSK TB 014 Project – A Phase II, Double Blind (Observer-Blind), Randomised, Controlled Study To Evaluate The Safety, Reactogenicity And Immunogenicity of GSK Biologicals’ Candidate Tuberculosis Vaccine (M72/As01e) When Administered Intramuscularly According To A 0,1 Month Schedule To HIV-Positive Adults Living In A TB Endemic Region

AMC #054 – A Single-Arm, Open-Label Pilot Study of the Safety and Immuno genicity of the Merck Quadrivalent Human Papillomavirus Vaccine among HIV-Positive Women in India: A Trial of the AIDS Malignancy: Clinical Trials Consortium (AMC).

SECONDLINE STUDY- A Randomised Open-Label Study comparing the Safety and Efficacy of Ritonavir boosted Lopinavir and 2-3N(T)RTI Backbone versus Ritonavir boosted Lopinavir and Raltegravir in Participants Virologically Failing First-Line NNRTI/2N(T)RTI Therapy

HIVIND – The Antiretroviral Roll out for HIV in India – Strengthening Capacity to Promote Adherence and Patient follow-up in the Context: A Research Plan for a Two-Centre, Randomized, Controlled, Open Trial in South India to Study an Innovative approach to Promote Adherence in HIV + Indian Patients

WRHI001-GATES- A Randomized, Double-Blind, Multi-Centre, Parallel-Group Phase 3b Study To Demonstrate Non-Inferiority Of Stavudine (20 Mg Twice Daily) Compared With Tenofovir Disoproxil Fumarate (300 Mg Once Daily) When Administered In Combination With Lamivudine And Efavirenz In Anti Retroviral-Naive Patients Infected With HIV-1

Posts navigation

Previous page Page 1 Page 2 Page 3 … Page 6 Next page
Get our YRG CARE Bulletin
  • Home
  • Research
  • News & Events
  • Min Siragugal
  • Donate
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
  • Refund Policy
  • Procurement Notices

Share This

Donate
Security Partner : Shieldfy

Make an Enquiry

  • max porno
  • porn videos
  • redwap in

Register